Site Search
Search Results
Advocates Hold Cancer Action Day at State House, Urging Lawmakers to Expand Access to Biomarker Testing & Address Affordability Concerns
CONCORD, NH —March 6, 2025— Earlier today, American Cancer Society Cancer Action Network (ACS CAN) volunteers rallied at the New Hampshire State House as a part of their annual Cancer Action Day advocating for several legislative proposals that aim to address the needs of patients across the cancer ... Specifically, the advocates urged support of a proposal to improve access to biomarker testing (SB 120) and legislation relative to insurance cost sharing calculations (SB 17). They also asked lawmakers to protect level funding for the state’s Tobacco Control & Cessation Program, the ...
California Assembly Committee Passes Legislation Requiring More Insurance Plans Cover Biomarker Testing Needed for Many Innovative Cancer Treatments
... Senate Bill 912 will enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for some cancer patients. But to determine if a patient will benefit from certain targeted therapies, doctors ... Ogden-Smith, California Legislative Director for the American Cancer Society Cancer Action Network (ACS CAN). “It’s imperative we dismantle cost barriers in order to address and help reduce health disparities.” Communities that have been under-resourced, including communities of ...
State Senate Committee Votes to Increase Access to Innovative Testing and Lifesaving Treatments
... evening to advance a bill that would increase access to biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for cancer patients. Senate Bill 912 would ensure comprehensive biomarker testing is covered by more ... medical centers are less likely to receive recommended biomarker testing. “We urge the legislature to pass this bill to help dismantle cost barriers and bring the promise of precision medicine to more cancer patients, regardless of their income, race or zip code,” said Autumn J. ...